It now covers up to 25 properties, with flexible options like contents, loss of rent, terrorism, and legal expenses. Intact has expanded the product to include larger risks, with mixed-use up to £5m, ...

In an exclusive interview for the Double Indemnity podcast series which will go live next week, Norgrove, pictured right, stated: “At the end of the day trading happens at a local site level. “We are ...

Intact Financial (TSX:IFC) has been catching investors’ attention, particularly with its recent performance in the Canadian insurance sector. Over the past month, shares have climbed about 5%. This ...

TORONTO, Nov. 12, 2025 /CNW/ - Intact Financial Corporation (TSX: IFC) ("Intact" or the "Company") announced today that it has closed its previously announced bought deal offering (the "Offering") of ...

RSA Insurance has officially rebranded to Intact Insurance across Ireland, the UK and Europe. The insurance company said the brand change unites the companies under a single global brand, reflecting a ...

Intact Insurance Specialty Solutions’ offers a broad range of specialty insurance products through independent agencies, regional and national brokers, wholesalers and managing general agencies. Each ...

Intact Financial is a blue-chip TSX dividend stock that should offer steady returns to shareholders over the next 18 months. It offers personal auto and property insurance, commercial and specialty ...

Valued at a market cap of almost $50 billion, Intact Financial (TSX:IFC) is among the largest companies in Canada. Intact Financial is a leading property and casualty insurance provider operating in ...

Effective solutions could help protect your home from extreme weather events, such as floods, hailstorms and wildfires You can save this article by registering for free here. Or sign-in if you have an ...

Intact Financial is a high-quality, dominant insurer with strong financials and a proven track record of compounding shareholder value over the long term. Despite operational excellence and strategic ...

Processa Pharmaceuticals, Inc. has announced a licensing agreement with Intact Therapeutics for PCS12852, a novel 5-HT4 receptor agonist aimed at treating gastroparesis and gastrointestinal motility ...